Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma

Published:2022-04 Issue: Volume:71 Page:101544
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Keruakous Amany R.,Asch Adam,Aljumaily Raid,Zhao Daniel,Yuen Carrie

Funder

University of Oklahoma Health Sciences Center

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference52 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

3. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016;Cowan;JAMA Oncol.,2018

4. The multiple myelomas - current concepts in cytogenetic classification and therapy;Kumar;Nat. Rev. Clin. Oncol.,2018

5. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients;Kumar;Leukemia.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma;Biomedicine & Pharmacotherapy;2024-07

2. Graft collection by apheresis and graft composition;Transfusion and Apheresis Science;2024-06

3. Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2024-02-12

4. Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling;Frontiers in Oncology;2023-10-02

5. Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation;Cells;2022-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3